The best magazine
In October, the US Food and Drug Administration (FDA) approved another agent as a counterterrorism measure, Radiogardase. Also approved was Namenda (memantine) as a novel treatment of moderate to severe dementia of the Alzheimer's type.
This month's column reviews FDA new product approvals and labeling changes for:
Alzheimer's disease
|
Antidiabetic agents
|
Antidepressants
|
Antiviral agents
|
Cardiovascular agents
|
Counterterrorism agents
|
Estrogens
|
Ophthalmic Agents
|
Source: ...